References
- Bronaugh RL, Stewart RF. Methods for in vitro percutaneous absorption studies V: Permeation through damaged skin. J Pharm Sci. 1985; 74(10): 1062–1066.
- Potts RO, Guy RH. A predictive algorithm for skin permeability: the effects of molecular size and hydrogen bond activity. Pharm Res. 1995; 12(11): 1628–1633.
- Cross SE, Innes B, Roberts MS, Tsuzuki T, Robertson TA, McCormick P. Human skin penetration of sunscreen nanoparticles: In-vitro assessment of a novel micronized zinc oxide formulation. Skin Pharmacology and Physiology. 2007; 20(3): 148–154.
- Lademann J, Weigmann HJ, Rickmeyer C, Barthelmes H, Schaefer H, Mueller G, Sterry W. Penetration of titanium dioxide microparticles in a sunscreen formulation into the horny layer and the follicular orifice. Skin Pharmacol Appl. 1999; 12(5): 247–256.
- Gamer AO, Leibold E, van Ravenzwaay B. The in vitro absorption of microfine zinc oxide and titanium dioxide through porcine skin. Toxicology in Vitro. 2006; 20(3): 301–307.
- Zhang LW, Monteiro-Riviere NA. Assessment of Quantum Dot Penetration into Intact, Tape- Stripped, Abraded and Flexed Rat Skin. Skin Pharmacology and Physiology. 2008; 21(3): 166–180.
- Raykar PV, Fung MC, Anderson BD. The role of protein and lipid domains in the uptake of solutes by human stratum corneum. Pharmaceutical Research. 1988; 5(3): 140–150.
- Scheuplein RJ, Blank IH. Permeability of the skin. Physiol Rev. 1971; 51(4): 702–747.
- Van der Merwe D, Brooks JD, Gehring R, Baynes RE, Monteiro-Riviere NA, Riviere JE. A Physiologically Based Pharmacokinetic Model of Organophosphate Dermal Absorption. Toxicol Sci. 2006; 89(1): 188–204.
- Tsuji JS. Research Strategies for Safety Evaluation of Nanomaterials, Part IV: Risk Assessment of Nanoparticles. Toxicological Sciences. 2005; 89(1): 42–50.